Triple-negative breast cancer (TNBC), endometrial cancer (EC), and epithelial ovarian cancer changes in the epidermal growth factor receptor (EGFR) have been linked to several malignancies. This evidence concerns the gene EGFR and triple-negative breast carcinoma.